Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 1.340
-0.030 (-2.19%)
Sep 4, 2026, 1:19 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 3.22 million as of September 3, 2026. Its market cap has decreased by -96.95% in one year.
Market Cap
3.22M
Enterprise Value
-16.92K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.34
ChartMarket Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 3.22M, a decrease of -98.37%. That is a compound annual growth rate of -54.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.43M | -96.31% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 68.52M |
| AcouSort AB | 67.72M |
| Modus Therapeutics Holding AB | 66.32M |
| OncoZenge AB | 62.58M |
| Fluicell AB | 43.00M |
| ExpreS2ion Biotech Holding AB | 33.13M |
| Alligator Bioscience AB | 16.14M |
| Aptahem AB | 13.64M |